Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens.
Limonciel A, van Breda SG, Jiang X, Tredwell GD, Wilmes A, Aschauer L, Siskos AP, Sachinidis A, Keun HC, Kopp-Schneider A, de Kok TM, Kleinjans JCS, Jennings P.
Limonciel A, et al. Among authors: van breda sg.
Front Genet. 2018 Dec 3;9:558. doi: 10.3389/fgene.2018.00558. eCollection 2018.
Front Genet. 2018.
PMID: 30559759
Free PMC article.